Xeroderma pigmentosum type C (XPC) is a rare autosomal recessive disorder that occurs due to inactivation of the XPC protein, an important DNA damage recognition protein involved in DNA nucleotide excision repair (NER). This defect, which prevents removal of a wide array of direct and indirect DNA lesions, is associated with a decrease in catalase activity. To test the hypothesis of a novel photoprotective approach, we irradiated epidermis reconstructed with XPC human keratinocytes sustainably overexpressing lentivirus-mediated catalase enzyme. Following UVB irradiation, there was a marked decrease in sunburn cell formation, caspase-3 activation and p53 accumulation in human XPC-reconstructed epidermis overexpressing catalase. Moreover, XPC-reconstructed epidermis was more resistant to UVB-induced apoptosis than normal reconstructed epidermis. While not correcting the gene defect, indirect gene therapy using antioxidant enzymes may be of help in limiting photosensitivity in XPC and probably in other monogenic/polygenic photosensitive disorders characterized by ROS accumulation.
Introduction
Xeroderma pigmentosum (XP) is an autosomal recessive disease due to defective nucleotide excision repair (NER). The defects in XP patients fall into seven NER complementation groups: XP-A to XP-G and a separate group XP variant (XP-V) due to a defect in DNA polymerase Z. XP patients have a high incidence of skin cancers (2000-fold that of the general population), which occur early in life in the first decade. 1, 2 Xeroderma pigmentosum type C (XPC) is one of the more common forms in Europe, USA and Japan. Heterozygotes are unaffected, whereas homozygotes have an early and severe sun sensitivity, which damages the skin and eyes. The disease begins in early life with the first exposure to sunlight, the median age of onset being 1-2 years of age, with skin rapidly exhibiting the signs associated with years of sun exposure. 1, 3, 4 The disorder is due to inactivation of the XPC protein, an important DNA damage recognition protein involved in NER, a highly versatile system capable of removing a wide variety of helix-distorting lesions from genomic DNA. 5 This system includes two distinct subpathways: global genome repair (GGR), which repairs DNA damage throughout the genome; and transcription-coupled repair (TCR), which repairs DNA lesions in the transcribed strand of active genes. 6 Defects in the XPC protein affect GGR and prevent the removal of a wide array of DNA damage, including ultraviolet-B (UVB)-induced photoproducts such as cyclobutane pyrimidine dimers (CPD) and 6-4 photoproducts. 7, 8 Apart from surgical removal of individual skin cancers, current therapy involves administration of systemic retinoids. 9 However, the most effective treatment of XP is stringent avoidance of all sources of UVB radiation from very early childhood. [10] [11] [12] Enzymatic therapy with liposomes containing bacteriophage T4 endonuclease V has been reported to reduce the frequency of skin cancer in addition to actinic keratoses in XP patients following topical treatment, possibly by enhancing DNA repair in the skin. 12 Complementing XPC gene, direct gene therapy has been successfully attempted in vitro and showed complete correction of repair-defected cellular phenotypes. 8, [13] [14] [15] UVB irradiation produces two types of DNA damage: direct lesions, which are due to the absorption of photons by nucleobases; and indirect damage, which is dependent on the production of reactive oxygen species (ROS: H 2 O 2 , OH, 1 O 2 y.). [16] [17] [18] [19] [20] Several studies have shown that keratinocyte exposure to UVB irradiation generates ROS in excessive quantities that quickly overwhelm various antioxidant defense systems including non-enzymatic (a-tocopherol and vitamin C) and enzymatic antioxidants (catalase and superoxide dismutase). [21] [22] [23] [24] UVB-induced ROS production leads to cytotoxicity through proteins, lipids and DNA oxidation both in vitro and in vivo. 21, [25] [26] [27] Unlike lipids and proteins, damaged DNA molecules cannot be replaced and need to be repaired. The repair of UVB-induced oxidative DNA damage is mediated by both the base excision repair (BER) and NER systems. Considering the consequences of the defect of the NER system in XP patients, the antioxidant defense system is likely pre-eminent, that is, by overstimulation, in reducing UVB-induced oxidative damage. Paradoxically, however, reduced catalase activity in these patients has already been documented. 28, 29 Reinforcement of the antioxidant enzymes may thus protect XP keratinocytes from UVB-induced oxidative stress. We recently demonstrated that overexpression of catalase had a protective effect against UVB-induced apoptosis in cultured normal human keratinocytes as well as reconstructed epidermis (RE). 22, 24 To test the hypothesis that reinforcement of internal photoprotectors can affect the phenotypic expression of severe photosensitive disorders, we extended our previous studies to epidermis reconstructed with XPC keratinocytes (XP-RE). We found that catalase overexpression can reduce UVB-induced apoptosis in XP-RE, and that reduced apoptosis is accompanied by a decrease in p53 accumulation. Moreover, our results demonstrate that XP-RE is paradoxically more resistant to UV-induced apoptosis than normal RE.
Methods

Source of keratinocytes and epidermal reconstruction
Xeroderma pigmentosum type C keratinocytes were isolated from punch biopsies obtained after informed consent from nonexposed body sites. Briefly, biopsies were immediately treated with trypsin-EDTA for 3 h at 37 1C, or overnight at 4 1C to separate the epidermis from the dermis. Keratinocytes were seeded on mitomycin C-treated feeder cells originating from the mouse fibroblast J2-3T3 cell line in complete Green's media, which included cholera toxin (8.5 ng ml À1 ), hydrocortisone (0.5 mg ml À1 ), epidermal growth factor (10 ng ml
À7 M) and 10% fetal serum. At confluence, cells were detached and resuspended in MCDB153 medium which included hydrocortisone (0.5 mg ml À1 ), epidermal growth factor (10 ng ml À1 ), insulin (5 mg ml À1 ) and bovine pituitary extract (70 mg ml À1 ) (all from Sigma, St Louis, MO). The medium was changed three times a week. When the culture reached 70-80% confluence, the cells were detached with trypsin-EDTA and then resuspended in MCDB153 medium, or were used to reconstruct epidermis. Normal keratinocytes were isolated from normal human skin in patients undergoing plastic surgery.
Preparation of reconstructed epidermis (RE)
Normal skin samples were cut into 1 Â 1 cm pieces and kept at 37 1C for 15 days. Then, dermis was separated from epidermis and kept at -80 1C. Normal and XP keratinocytes were seeded at 4 Â 10 5 cells cm À2 on the dead dermis. Twenty-four hours later, the dermis was immersed in culture medium for 72 h to allow cell proliferation. Then, it was placed at the air/liquid interface for 7 days to allow differentiation. 30 Figure 2a) . Lentiviral particles were produced by transient transfection of 293T cells using a calcium phosphate transfection technique. The following plasmids were used: a packaging plasmid (pCMVD8.91), an envelope plasmid (pMD.G) from the vesicular stomatitis virus glycoprotein envelope (VSV-G) and transfer vectors (TPW, TPEW or TPCATW) as described previously. 22, 24 After 48 h, the viral supernatant was harvested, filtered through 0.22 mm filter, centrifuged at 35 000 g for 4 h and frozen in aliquots. Determination of the titer of each viral supernatant was performed by assessing EGFP expression by flow cytometry and p24 using an enzyme-linked immunosorbent assay.
Construction and production of lentiviral vectors
Transduction of keratinocytes
A total of 5 Â 10 5 cells were plated in T25 flasks and incubated for 24 h in complete medium. Before infection, medium was removed and cells were infected with viral supernatants for 24 h at 37 1C in the presence of 8 mg ml À1 protamine sulfate. After 5 days, the cells were trypsinized and used for the preparation of reconstructed epidermis. Before reconstruction, the percentage of EGFP-positive cells was analyzed by cytofluorimetry.
Irradiation procedure Ultraviolet-B irradiation was delivered with a Biotronic device (Vilber Lourmat, Marne la Valle´e, France) equipped with a dosimeter as already described. 22, 24 Briefly, the UVB lamp emitted a continuous spectrum between 280 and 380 nm, with a major peak at 312 nm. After rinsing with PBS, RE were irradiated at a dose of 180 or 220 mJ cm À2 UVB. These doses were chosen after preliminary tests to induce significant levels of apoptosis (20 and 40%) in the basal layer of normal RE. Following irradiation, samples were rinsed with PBS and incubated in fresh medium.
Histological and immunohistochemical studies
Reconstructs were fixed in 4% formaldehyde, embedded in paraffin, cut in 5 mm sections and stained with hematoxylin-eosin to assess the general morphology of the epidermis and the amount of sunburn cells (SBC). We counted 100 cells each time on 10 different areas for quantification of SBC. To verify transduction efficiency, the sections of epidermis reconstructed with keratinocytes transduced by EGFP (RE/EGFP) were incubated with a monoclonal antibody against EGFP (Santa Cruz Biotechnology, TEBU, Le Perray en Yvelines, France) and were then counterstained with hematoxylin. Accumulation of p53 protein and cyclobutane pyrimidine dimers (CPD) was detected 24 h after irradiation using the anti-human p53 antibody (clone DO-7, Dako, Trappes, France) and the mouse monoclonal antibody TDM-2 (generous gift from O Nikaido, Kanawaza University, Japan), respectively. Revelation was performed using the EnVision þ HRP kit (Dako, Trappes, France), which enhances staining sensitivity.
Determination of catalase activity
Frozen reconstructs were thawed. The epidermis was separated from the dermis, homogenized with a Potter homogenizer in 0.1 M Tris-Cl (pH 7.5) and then sonicated for two 15-s bursts. After 10 min of centrifugation at 12 000 g, aliquots of the obtained supernatant were stored at À80 1C. The total protein content of each epidermis was measured by the BCA kit reagent (Pierce, Bezons, France). Catalase enzyme activity was measured by the Amplex Red Catalase Assay kit (Molecular Probes, Invitrogen, Cergy-Pontoise, France). A standard curve for the catalase activity was plotted using a purified enzyme preparation. Enzyme-specific activity was expressed as unit per mg protein in epidermis homogenate. One unit of catalase activity was defined as 1 mmol H 2 O 2 consumed per minute.
Protein quantification by western blotting
Western blotting was performed as previously described. 18, 19 Briefly, epidermis was separated from dermis, homogenized with a Potter homogenizer in lysis buffer (25 mM HEPES pH 7.4, 150 mM NaCl, Triton X-100 1% v/v) and then incubated at 4 1C for 30 min. After 10 min of centrifugation at 12 000 g, aliquots of the supernatant were stored at À80 1C. Total protein content of each epidermis was measured by the BCA kit reagent (Pierce). Equal amounts of total protein were resolved by SDS-polyacrylamide gel electrophoresis (12% gel) and electrophoretically transferred to a polyvinylidine difluoride membrane at 1.2 V cm À2 for 1 h 20 min. After blocking the membranes with 5% nonfat dry milk in Tris-buffered saline with 0.1% Tween 20 (TBS-T) for 1 h at room temperature in a shaker, the blots were incubated at 4 1C with 1:1000 dilution of the anticatalase (Rockland, TEBU, Le Perray en Yvelines, France), anti-XPC (Gene Tex, Euromedex, Mundolsheim, France) or anti-caspase-3 monoclonal antibodies (Cell Signaling Technology, TEBU). After overnight incubation, the blots were washed with TBS-T (3 Â 10 min) and incubated for 1 h at room temperature with 1:10000 diluted antiimmunoglobin horseradish peroxidase-linked antibody (Vector Laboratories, Biovalley SA, Marne la Valle´e, France). After washing the membrane three times for 10 min with TBS-T and twice with TBS alone, the chemiluminescence ECL reagent was used to develop the blots.
XPC gene analysis
Genomic DNA was extracted from primary cultured keratinocytes obtained from XPC patients by using the Wizard genomic DNA purification kit (Promega, Charbonnie`re, France). PCR amplification and sequencing of XPC exons, including splice consensus sequences, were performed according to Khan et 
Results
XPC molecular analyses
Five unrelated patients clinically classified as classical XP with no associated neurologic or extracutaneous findings were included in the study. To measure the XPC protein level in XPC affected cells, western blot analyses were performed on total cellular extracts using anti-XPC and anti-b-actin antibodies (monoclonal and polyclonal, respectively). Although XPC protein was readily measured in the normal cells, neither the full-length nor the truncated XPC protein was detectable in the keratinocytes from the five XPC patients (Figure 1 ). Two previously described mutants of the XPC gene [32] [33] [34] were identified at the homozygous state in four patients: the frameshift mutant (c1639delTG) was present in three patients and the nonsense mutant (pR220X) was present once. The mutation was not determined in one of the patients for whom further analyses (for example, microdeletion studies) were required to explain the lack of expression of XPC at the protein level. High efficiency of lentiviral vector-mediated gene transfer in normal and XPC keratinocytes As previously shown, lentiviral vectors provide high efficiency and sustained transgene expression in normal human keratinocytes. [22] [23] [24] In this study, the same type of lentivectors was used for the transduction of XPC keratinocytes to overexpress either the marker gene EGFP (TPEW) or the 'therapeutic' gene catalase (TPCATW) (Figure 2a) . The percentage of EGFPpositive cells assessed by cytofluometry 5 days post-transduction reached 85-95% both in normal and XPC cells (Figure 2b ). As shown in Figure 2c , basal catalase activity was lower in XPC than in normal keratinocytes (18±10 versus 30±6 U mg À1 protein). Following transduction with TPCATW, the specificactivity of catalase increased in the same manner in both XPC and normal keratinocytes (9.4 and 7.3-fold, respectively). Western blot analyses using anticatalase antibody showed the same quantity of catalase in non-transduced XPC and normal keratinocytes. Our results also indicated a similar increase at the protein level following catalase transduction when comparing non-transduced and transduced XPC and normal keratinocytes (Figure 2d ).
Efficient transgene expression in RE
We next examined whether XPC keratinocytes were able to develop into a fully stratified epidermis with basal, suprabasal, granular and cornified layers. Histological examination of reconstructed epidermis revealed similar architectures when using either non-transduced normal or XPC keratinocytes (RE/NT and XP-RE/NT), as shown in Figure 3a . The same observation was obtained using transduced keratinocytes. To determine whether the genes transferred by lentivectors were expressed in RE and XP-RE in the same manner, expression of EGFP was assessed by immunohistochemistry using an anti-EGFP antibody. Our results demonstrated that EGFP-positive cells were located in all the layers of both RE/GFP and XP-RE/ GFP (Figure 3b ). Catalase activity was also measured in RE and XP-RE for this purpose. A 38% decrease in catalase basal activity was observed in XP-RE/NT compared with RE/NT (235 ± 50 and 379 ± 100 U mg À1 protein, respectively; Po0.05) (Figure 3c ). The increase in catalase activity was similar in reconstructed epidermis made from either catalase-transduced XPC (XP-RE/CAT) or catalase-transduced normal keratinocyte (RE/CAT), compared with non-transduced reconstructs (XP-RE/NT and RE/NT, respectively) (Figure 3c ). Western blot analyses showed equivalent amounts of catalase in both RE/NT and XP-RE/NT, and a similar increase following transduction (Figure 3d ).
Increased catalase activity and protein levels in XP-RE/NT and RE/NT following UVB irradiation
To study the effects of UVB (180 or 220 mJ cm À2 ) irradiation upon catalase expression, catalase activity was measured in normal RE and XP-RE (Figure 3c ). Twenty-four hours after irradiation, catalase activity increased 1.8 and 1.7-fold in XP-RE/NT and RE/NT, respectively, as compared with non-irradiated counterparts (Figure 3c ). Western blot analysis indicated that the increase in catalase activity following irradiation was not associated with an increase in catalase protein level (Figure 3d ).
Decrease in UVB-induced apoptosis in RE and XP-RE overexpressing catalase One of the major biological features of UVB is the induction of apoptotic cell death of keratinocytes, which appear as sunburn cells (SBC) within the epidermis. To investigate the effect of catalase overexpression on apoptosis, the formation of SBC following UVB exposure was first detected by classical histology (Figure 4a ) and quantified in all types of RE and XP-RE in the total epidermis and in the various epidermal strata (Table 1) . Whatever the UVB dosage (180 or 220 mJ cm À2 ), the number of SBC was lower in XP-RE than in normal RE, especially in the basal layer (8 versus 25.2%; see Table 1 and Figure 4a) . Furthermore, the number of SBC was lower in RE/CAT and XP-RE/CAT (approximately 40%) than in RE/NT and XP-RE/NT (Table 1) . We then calculated the percentage of SBC within each epidermal layer (Table 1) . In RE/NT and XP-RE/NT, SBC appeared in the basal layer and stratum spinosum. In epidermis overexpressing catalase (RE/CAT and XP-RE/ CAT), SBC decreased markedly (75-80%) in the basal layer but remained constant in the stratum spinosum. To assess the global rate of apoptotic cells (SBC), caspase-3 activation was examined using specific antibody staining. Immunoblot analyses again revealed a clear decrease in caspase-3 activation in XP-RE compared with RE. Furthermore, this test demonstrated that catalase overexpression significantly reduced caspase-3 activation following UVB irradiation in both normal RE and XP-RE (Figure 4b ).
Reduction of p53 accumulation (but not CPD formation) following UVB irradiation in RE and XP-RE overexpressing catalase
To investigate whether the reduction of UVB-induced apoptosis upon catalase overexpression was associated with a decrease in DNA damage, total p53 was assessed by immunohistochemical analysis. As shown in Figure 5 , p53 protein did not accumulate in non-irradiated normal RE and XP-RE with or without catalase overexpression ( Figure 5 ). Twenty-four hours after UVB irradiation, p53 accumulation was higher in XP-RE/NT than RE/NT. Moreover, catalase overexpression decreased p53 accumulation both in normal and XP-RE ( Figure 5) . Lastly, the formation of CPD following irradiation was assessed using a specific antibody. As expected, the number of positive nuclei was significantly higher in UVB-irradiated XP-RE/NT than in normal RE/NT. Our results also indicated that catalase overexpresion had no effect on CPD formation in both types of irradiated RE ( Figure 6 ). These data indicate that the reduction of UVB-induced oxidative DNA damage and consequently the decrease in p53 accumulation in RE upon catalase overexpression could be responsible for the reduction of UVB-induced apoptosis.
Discussion
UV irradiation is clearly implicated in premature skin aging and cancer. These features are intensified in patients with XPC, one of the most common forms of XP disease associated at the cellular level with DNA repair defects and low catalase activity. Our study indicates that catalase overexpression protects XPC-reconstructed epidermis against the deleterious effects of acute UVB irradiation, and suggests that the importance of antioxidant defenses in this setting should be reconsidered.
XPC gene defect
The XPC protein is required for the initial phases of the GGR pathway of the NER system. As a consequence, XPC inactivation results in sun sensitivity and increased risk of skin cancer (2000-fold increased incidence). [3] [4] [5] In agreement with previous findings, [32] [33] [34] the patients in this study had no detectable XPC protein in keratinocytes obtained from skin biopsies, and two functional mutants (c1639delTG and pR220X) of the XPC gene were identified. Recent unpublished data from our laboratory have shown that the (c1639delTG) mutant is highly prevalent in XP patients from North Africa, and is associated with a high level of consanguinity. Most mutants of the XPC gene lead to the absence of full length XPC protein due to nonsense, frame-shift deletion or aberrant splicing mutations, and only two inactivating mutants have been described. 35 The absence of detectable protein is explained by nonsense-mediated RNA decay (NMD), a pathway responsible for the degradation of mRNA that cannot be translated along their full length. This reduces the accumulation of deleterious truncated proteins. 35 The proliferation and viability of normal and XPC keratinocytes were similar in primary cultures (data not shown). Furthermore, XPC keratinocytes yielded a normal architecture compared with normal cells, indicating that the XPC protein is not essential for cell viability, proliferation or development.
Bernerd et al. 36 showed that reconstruction of XPC epidermis led to satisfactory features of stratification and differentiation in spite of differences in the expression of some differentiation markers such as loricin, filaggrin and keratin 10. Furthermore, their team has shown that reconstructed XPC skin using XPC keratinocytes and XPC fibroblasts displays striking epidermal invasions reminiscent of the early steps of epidermal neoplastic development. 36 Thus, the effects of catalase overexpression on fully reconstructed skin (including XP keratinocytes and XP fibroblasts) and epidermal invasions deserve to be investigated in further studies.
Catalase protein level and enzyme activity in XPC keratinocytes and reconstructed epidermis Xeroderma pigmentosum type C keratinocytes and XP-RE showed reduced catalase activity compared with their normal counterparts, although protein levels were identical. This is in agreement with a previous report 37 indicating that decreased catalase activity in XP patients is related to a reduction in NADPH rather than to the catalase protein level. Our results indicated a 35% reduction in catalase activity in XPC keratinocytes and XP/RE compared with normal counterparts, whereas Vuillaume and co-workers, 28, 29 reported at least a 50% decrease in catalase activity in XP fibroblast lines. The differences between our results and those of Vuillaume et al. 28, 29 might be due to the type of cells used.
XP-RE are more resistant to UVB-induced apoptosis than normal RE As shown in Figure 4 and Table 1 , XP-RE was more resistant to UVB-induced apoptosis than normal RE. Accordingly, apoptosis levels have been shown to be similar or lower in XPC fibroblasts or keratinocytes compared with wild-type cells following UVC 38 or UVB irradiation. 39 Similarly, Ananthaswamy et al. 40 reported that XPC À/À mouse skin was more resistant to apoptosis following chronic UV irradiation than wild-type skin. The same levels of UV-induced apoptosis in XPC cells and normal cells are consistent with the idea that failure to repair UV damage (especially CPD) in the transcriptionally silent regions of the genome or in the non-transcribed strand of active genes does not induce apoptosis. 38 To explain the reduction of apoptosis in XPC-reconstructed epidermis compared with normal counterparts, one could hypothesize that the XPC protein acts as an initiating factor in the DNA damage-mediated signal transduction process, which results in DNA repair or apoptosis. Microarray studies of cisplatin-treated XPC and normal fibroblasts indicated that cell cycle and cell proliferation-related genes are mainly affected by the XPC gene defect. 41 For example, the activation of caspase-3 was much lower in cisplatin-treated XPC cells, in agreement with our results.
Reduction of apoptosis by catalase overexpression
In our system, UVB-induced CPD analyses confirmed the data of Bernerd et al. 13 showing a higher number of CPD-positive nuclei in XP than normal RE. In our experiments, catalase overexpression did not affect CPD formation in XP or normal epidermis. Since CPD is a nonoxidative product of UV-induced DNA damage, this result was not unexpected. Similarly, treatment of RE with a-tocopherol (a natural antioxidant) or polyunsaturated fatty acids (PUFA), which increased lipid, protein and DNA oxidation and apoptosis due to ROS production, did not increase CPD formation. 42, 43 The significant effect of catalase overexpression on the reduction of UVB-induced apoptosis without affecting CPD formation-the main UVB-induced DNA photoproduct-is surprising. We have recently demonstrated that UVB induces ROS production at two distinct chronologic stages: immediately following irradiation and 2-3 h after irradiation. 23, 24 The delayed increase in ROS production, which is persistent for a few hours, is completely prevented by catalase overexpression in keratinocytes. 23, 24 Thus, the protective effect of catalase overexpression may be due to the mitigation of DNA damage caused by the late increase in ROS levels. In this regard, it has recently been shown that XPC protein plays an important role in cell protection from oxidative DNA damage, and that the absence of XPC is associated with a decreased repair rate of 8-hydroxyguanine. 44 The accumulation of endogenous oxidative DNA damage might contribute to increased skin cancer risk and account for the higher frequency of internal cancers in XPC patients, which was until now difficult to understand.
To determine whether a reduction of UVB-induced apoptosis by catalase overexpression allows keratinocytes with DNA damage to survive and subsequently undergo malignant transformation, we compared p53 accumulation in XP and normal RE. The tumor-suppressor protein p53 accumulates following various stresses including DNA-damaging agents, oxidative stress and UV irradiation. [45] [46] [47] p53 transcriptionally activates genes encoding proteins involved in cell cycle arrest, DNA repair and/or apoptosis, and represses transcriptional activation of growth-promoting genes. [48] [49] [50] Our results showed that p53 accumulation following UVB irradiation was higher in XPC than in normal epidermis. This may be due to a defect in the CPD and/or oxidative DNA damage repair systems. Furthermore, catalase overexpression was able to reduce p53 accumulation in both XP and normal epidermis. Since p53 accumulation occurs in response to UVB-induced indirect as well as direct (CPD) DNA damage, the effect of catalase overexpression is likely restricted to the indirect pathway.
Conclusion
Direct gene therapy 8, [13] [14] [15] has been attempted successfully in vitro in XP-C. However, in vivo attempts will probably be problematic because of the complete absence of the protein in affected patients, which means that an intense immune reaction is likely in case of synthesis recovery. Our study indicates that, while not correcting the gene defect, indirect gene therapy using antioxidant enzymes may be of help in limiting photosensitivity in XPC (and probably in other XP patients), one of the most severe disorders of natural photoprotection. Preliminary studies in our laboratory have shown that catalase overexpression can be sustained for several months in nude mice xenografted with transduced reconstructed human epidermis. 51 This approach, which needs an adapted topical delivery system, may lead in future to the improved management of this orphan disorder, possibly in combination with nonspecific enzyme replacement. 12 Abbreviations CAT, catalase; CPD, cyclobutane pyrimidine dimer; GGR, global genome repair; NER, nucleotide excision repair; nIr, non-irradiated; NT, non-transduced; RE, normal reconstructed epidermis; SBC, sunburn cell; TCR, transcription-coupled repair; XP, xeroderma pigmentosum; XP-RE, epidermis reconstructed with XPC keratinocytes.
